Publication scientifique

Depressive Symptoms and Amyloid Pathology. (Wiels WA. et al., 2025)

Citation : Wiels, W. A., Oomens, J. E., Engelborghs, S., Baeken, C., von Arnim, C. A. F., Boada, M., Didic, M., Dubois, B., Fladby, T., van der Flier, W. M., Frisoni, G. B., Fröhlich, L., Gill, K. D., Grimmer, T., Hildebrandt, H., Hort, J., Itoh, Y., Iwatsubo, T., Klimkowicz-Mrowiec, A., Lee, D. Y., … Zettergren, […]

Depressive Symptoms and Amyloid Pathology. (Wiels WA. et al., 2025) Read More »

Plasma p-tau217 identifies cognitively normal older adults who will develop cognitive impairment in a 10-year window. (Yakoub Y. et Al., 2025)

Citation : Yakoub, Y., Gonzalez-Ortiz, F., Ashton, N. J., Déry, C., Strikwerda-Brown, C., St-Onge, F., Ourry, V., Schöll, M., Geddes, M. R., Ducharme, S., Montembeault, M., Rosa-Neto, P., Soucy, J. P., Breitner, J. C. S., Zetterberg, H., Blennow, K., Poirier, J., Villeneuve, S., & PREVENT−AD Research Group (2025). Plasma p-tau217 identifies cognitively normal older adults

Plasma p-tau217 identifies cognitively normal older adults who will develop cognitive impairment in a 10-year window. (Yakoub Y. et Al., 2025) Read More »

Precuneus Activity during Retrieval Is Positively Associated with Amyloid Burden in Cognitively Normal Older APOE 4 Carriers. (Fisher L. et al., 2025)

Citation : Fischer, L., Molloy, E. N., Pichet Binette, A., Vockert, N., Marquardt, J., Pacha Pilar, A., Kreissl, M. C., Remz, J., Tremblay-Mercier, J., Poirier, J., Rajah, M. N., Villeneuve, S., PREVENT-AD Research Group, & Maass, A. (2025). Precuneus Activity during Retrieval Is Positively Associated with Amyloid Burden in Cognitively Normal Older APOE4 Carriers. The

Precuneus Activity during Retrieval Is Positively Associated with Amyloid Burden in Cognitively Normal Older APOE 4 Carriers. (Fisher L. et al., 2025) Read More »

Novel synaptic markers predict early tau pathology and cognitive deficit in an asymptomatic population at risk of Alzheimer’s disease. (Ao J. et Al., 2025)

Citation : Ao, J., Picard, C., Auld, D., Zetterberg, H., Brinkmalm, A., Blennow, K., Villeneuve, S., Breitner, J. C. S., Poirier, J., & PREVENT-AD research group (2025). Novel synaptic markers predict early tau pathology and cognitive deficit in an asymptomatic population at risk of Alzheimer’s disease. Molecular psychiatry, 10.1038/s41380-024-02884-z. Advance online publication. https://doi.org/10.1038/s41380-024-02884-z Full text

Novel synaptic markers predict early tau pathology and cognitive deficit in an asymptomatic population at risk of Alzheimer’s disease. (Ao J. et Al., 2025) Read More »

Protocol for an intergenerational randomized controlled trial to enhance physical activity in older adults at risk for Alzheimer’s disease. (Walker et al., 2025)

Citation : Walker, C. S., Noriega de la Colina, A. E., Li, L., Boulanger, C., Thovinakere, N., Noly-Gandon, A., Barnoin, G., Bennett, M., Caplan, J., Côté, L., Elbaz, S., Bao, S. F. K., Kara, R., Lavoie, N., Nguyen, M., Otaner, F., Pallett-Wiesel, H., Piché, J. V., Powers, A., Ricciardelli, S., … PREVENT-AD Research Group (2025).

Protocol for an intergenerational randomized controlled trial to enhance physical activity in older adults at risk for Alzheimer’s disease. (Walker et al., 2025) Read More »

Synergistic association of Aβ and tau pathology with cortical neurophysiology and cognitive decline in asymptomatic older adults. (Weisman et al., 2024)

Citation : Gallego-Rudolf, J., Wiesman, A. I., Pichet Binette, A., Villeneuve, S., Baillet, S., & PREVENT-AD Research Group (2024). Synergistic association of Aβ and tau pathology with cortical neurophysiology and cognitive decline in asymptomatic older adults. Nature neuroscience, 27(11), 2130–2137. https://doi.org/10.1038/s41593-024-01763-8 Full text : Here Synergistic association of Aβ and tau pathology with cortical neurophysiology

Synergistic association of Aβ and tau pathology with cortical neurophysiology and cognitive decline in asymptomatic older adults. (Weisman et al., 2024) Read More »

Apolipoprotein B gene expression and regulation in relation to Alzheimer’s disease pathophysiology. (Aumont et al., 2024)

Citation : Aumont-Rodrigue, G., Picard, C., Labonté, A., & Poirier, J. (2024). Apolipoprotein B gene expression and regulation in relation to Alzheimer’s disease pathophysiology. Journal of lipid research, 65(11), 100667. https://doi.org/10.1016/j.jlr.2024.100667. Full text : Here Apolipoprotein B gene expression and regulation in relation to Alzheimer’s disease pathophysiology Aumont G, Picard C, Labonté A, the Alzheimer’s

Apolipoprotein B gene expression and regulation in relation to Alzheimer’s disease pathophysiology. (Aumont et al., 2024) Read More »

Genetic and clinical correlates of two neuroanatomical AI dimensions in the Alzheimer’s disease continuum. (Wen et al., 2024)

Citation : Wen, J., Yang, Z., Nasrallah, I. M., Cui, Y., Erus, G., Srinivasan, D., Abdulkadir, A., Mamourian, E., Hwang, G., Singh, A., Bergman, M., Bao, J., Varol, E., Zhou, Z., Boquet-Pujadas, A., Chen, J., Toga, A. W., Saykin, A. J., Hohman, T. J., Thompson, P. M., … Davatzikos, C. (2024). Genetic and clinical correlates

Genetic and clinical correlates of two neuroanatomical AI dimensions in the Alzheimer’s disease continuum. (Wen et al., 2024) Read More »

Osteopontin: A novel marker of pre-symptomatic sporadic Alzheimer’s disease. (Quesnel et al., 2024)

Citation : Quesnel, M. J., Labonté, A., Picard, C., Bowie, D. C., Zetterberg, H., Blennow, K., Brinkmalm, A., Villeneuve, S., Poirier, J., Alzheimer’s Disease Neuroimaging Initiative, & PREVENT‐AD Research Group (2024). Osteopontin: A novel marker of pre-symptomatic sporadic Alzheimer’s disease. Alzheimer’s & dementia : the journal of the Alzheimer’s Association, 20(9), 6008–6031. https://doi.org/10.1002/alz.14065 Full text

Osteopontin: A novel marker of pre-symptomatic sporadic Alzheimer’s disease. (Quesnel et al., 2024) Read More »

Neurochemical organization of cortical proteinopathy and neurophysiology along the Alzheimer’s disease continuum. (Weisman et al., 2024)

Citation : Wiesman, A. I., Gallego-Rudolf, J., Villeneuve, S., Baillet, S., Wilson, T. W., & PREVENT‐AD Research Group (2024). Neurochemical organization of cortical proteinopathy and neurophysiology along the Alzheimer’s disease continuum. Alzheimer’s & dementia : the journal of the Alzheimer’s Association, 20(9), 6316–6331. https://doi.org/10.1002/alz.14110 Full text : Here Neurochemical organization of cortical proteinopathy and neurophysiology

Neurochemical organization of cortical proteinopathy and neurophysiology along the Alzheimer’s disease continuum. (Weisman et al., 2024) Read More »